• 1
    Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999; 10: 41324.
  • 2
    Murphy ED, Roths JB. Autoimmunity and lymphoproliferation: induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In: RoseNR, BigazziPE, WernerNL, editors. Genetic control of autoimmune disease. New York: Elsevier North Holland; 1979. p. 20720.
  • 3
    Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, et al. Spontaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains. J Exp Med 1978; 148: 1198215.
  • 4
    Guardiola J, Maffei A. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases [review]. Crit Rev Immunol 1993; 13: 24768.
  • 5
    Ting JP, Baldwin AS. Regulation of MHC gene expression. Curr Opin Immunol 1993; 5: 816.
  • 6
    Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 1994; 265: 1069.
  • 7
    Cheah PL, Looi LM, Chua CT, Yap SF, Fleming S. Enhanced major histocompatibility complex (MHC) class II antigen expression in lupus nephritis. Malays J Pathol 1997; 19: 11520.
  • 8
    Boucher A, Droz D, Adafer E, Noel LH. Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int 1986; 29: 10439.
  • 9
    Wuthrich RP, Yui MA, Mazoujian G, Nabavi N, Glimcher LH, Kelley VE. Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis. Am J Pathol 1989; 134: 4551.
  • 10
    Yokoyama H, Takabatake T, Takaeda M, Wada T, Naito T, Ikeda K, et al. Up-regulated MHC-class II expression and γ-IFN and soluble IL-2R in lupus nephritis. Kidney Int 1992; 42: 75563.
  • 11
    Krief P, Augery-Bourget Y, Plaisance S, Merck MF, Assier E, Tanchou V, et al. A new cytokine (IK) down-regulating HLA class II: monoclonal antibodies, cloning and chromosome localization. Oncogene 1994; 9: 344956.
  • 12
    Vedrenne J, Assier E, Pereno R, Bouzinba-Segard H, Azzarone B, Jasmin C, et al. Inhibitor (IK) of IFN-γ induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line. Oncogene 1997; 14: 145361.
  • 13
    Cao LX, Le Bousse-Kerdiles MC, Clay D, Oshevski S, Jasmin C, Krief P. Implication of a new molecule IK in CD34+ hematopoietic progenitor cell proliferation and differentiation. Blood 1997; 89: 361523.
  • 14
    Hasegawa H, Kohno M, Sasaki M, Inoue A, Ito MR, Terada M, et al. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. Arthritis Rheum 2003; 48: 255566.
  • 15
    Inoue A, Hasegawa H, Kohno M, Ito MR, Terada M, Imai T, et al. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum 2005; 52: 152233.
  • 16
    Ito MR, Terasaki S, Itoh J, Katoh H, Yonehara S, Nose M. Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand. Arthritis Rheum 1997; 40: 105463.
  • 17
    Lee YN, Lee HY, Kang HK, Kwak JY, Bae YS. Phosphatidic acid positively regulates LPS-induced differentiation of RAW264.7 murine macrophage cell line into dendritic-like cells. Biochem Biophys Res Commun 2004; 318: 83945.
  • 18
    O'Keefe GM, Nguyen VT, Ping Tang LL, Benveniste EN. IFN-γ regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein. J Immunol 2001; 166: 22609.
  • 19
    Assier E, Bouzinba-Segard H, Stolzenberg MC, Stephens R, Bardos J, Freemont P, et al. Isolation, sequencing and expression of RED, a novel human gene encoding an acidic-basic dipeptide repeat. Gene 1999; 230: 14554.
  • 20
    Hasegawa H, Nomura T, Kohno M, Tateishi N, Suzuki Y, Maeda N, et al. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood 2000; 95: 308.
  • 21
    Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 1939.
  • 22
    Hasegawa H, Utsunomiya Y, Kishimoto K, Yanagisawa K, Fujita S. SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily [published erratum appears in J Virol 1997;71:1737]. J Virol 1996; 70: 325863.
  • 23
    Yanagi K, Haneji N, Hamano H, Takahashi M, Higashiyama H, Hayashi Y. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice. Cell Immunol 1996; 168: 24350.
  • 24
    Lawman S, Mauri C, Jury EC, Cook HT, Ehrenstein MR. Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice. J Immunol 2004; 173: 76416.
  • 25
    Bost KL, Bieligk SC, Jaffe BM. Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies: tumor-derived IL-10 as a possible mechanism for modulating the anti-tumor response. J Immunol 1995; 154: 71829.
  • 26
    Sasaki M, Hasegawa H, Kohno M, Inoue A, Ito MR, Fujita S. Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice. J Immunol 2003; 170: 58896.
  • 27
    Han IS, Ra JS, Kim MW, Lee EA, Jun HY, Park SK, et al. Differentiation of CD34+ cells from human cord blood and murine bone marrow is suppressed by C6 β-chemokines. Mol Cells 2003; 15: 17680.
  • 28
    Haas C, Ryffel B, Le Hir M. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J Immunol 1997; 158: 548491.
  • 29
    Balomenos D, Rumold R, Theofilopoulos AN. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest 1998; 101: 36471.
  • 30
    Lawson BR, Prud'homme GJ, Chang Y, Gardner HA, Kuan J, Kono DH, et al. Treatment of murine lupus with cDNA encoding IFN-γR/Fc. J Clin Invest 2000; 106: 20715.
  • 31
    Carvalho-Pinto CE, Garcia MI, Mellado M, Rodriguez-Frade JM, Martin-Caballero J, Flores J, et al. Autocrine production of IFN-γ by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice. J Immunol 2002; 169: 105867.
  • 32
    Jabs DA, Prendergast RA. Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4. J Exp Med 1987; 166: 1198203.
  • 33
    Giese T, Davidson WF. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr. J Immunol 1992; 149: 3097106.
  • 34
    Shlomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 1994; 180: 1295306.
  • 35
    Chan O, Shlomchik MJ. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J Immunol 1998; 160: 519.
  • 36
    Freed JH, Marrs A, VanderWall J, Cohen PL, Eisenberg RA. MHC class II-bound self peptides from autoimmune MRL/lpr mice reveal potential T cell epitopes for autoantibody production in murine systemic lupus erythematosus. J Immunol 2000; 164: 4697705.
  • 37
    Suh CH, Freed JH, Cohen PL. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice. J Immunol 2003; 170: 222935.
  • 38
    Zhou T, Bluethmann H, Eldridge J, Berry K, Mountz JD. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice: clues from a T cell receptor β transgenic mouse. J Immunol 1993; 150: 345167.
  • 39
    Herron LR, Eisenberg RA, Roper E, Kakkanaiah VN, Cohen PL, Kotzin BL. Selection of the T cell receptor repertoire in Lpr mice. J Immunol 1993; 151: 34509.
  • 40
    Jonsson R, Holmdahl R. Infiltrating mononuclear cells in salivary glands and kidneys in autoimmune MRL/Mp-lpr/lpr mice express IL-2 receptor and produce interferon-γ. J Oral Pathol Med 1990; 19: 3304.
  • 41
    Jevnikar AM, Grusby MJ, Glimcher LH. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med 1994; 179: 113743.
  • 42
    Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 2000; 6: 1399402.